Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 20 studies | 31% ± 15% | |
| astrocyte | 15 studies | 37% ± 18% | |
| microglial cell | 12 studies | 35% ± 12% | |
| oligodendrocyte | 12 studies | 30% ± 12% | |
| oligodendrocyte precursor cell | 11 studies | 37% ± 15% | |
| macrophage | 10 studies | 34% ± 14% | |
| fibroblast | 10 studies | 29% ± 13% | |
| adipocyte | 9 studies | 28% ± 8% | |
| dendritic cell | 9 studies | 35% ± 16% | |
| GABAergic neuron | 8 studies | 43% ± 20% | |
| B cell | 7 studies | 23% ± 8% | |
| natural killer cell | 7 studies | 23% ± 7% | |
| myeloid cell | 7 studies | 24% ± 7% | |
| glutamatergic neuron | 6 studies | 45% ± 23% | |
| interneuron | 6 studies | 44% ± 22% | |
| plasmacytoid dendritic cell | 6 studies | 26% ± 7% | |
| mast cell | 6 studies | 23% ± 5% | |
| endothelial cell of lymphatic vessel | 6 studies | 32% ± 12% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 22% ± 3% | |
| epithelial cell | 5 studies | 39% ± 25% | |
| T cell | 5 studies | 23% ± 6% | |
| monocyte | 5 studies | 34% ± 11% | |
| pericyte | 5 studies | 31% ± 13% | |
| smooth muscle cell | 5 studies | 28% ± 4% | |
| type I pneumocyte | 5 studies | 27% ± 9% | |
| type II pneumocyte | 5 studies | 29% ± 7% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 20% ± 5% | |
| granule cell | 4 studies | 23% ± 4% | |
| neuron | 4 studies | 51% ± 18% | |
| naive B cell | 4 studies | 19% ± 2% | |
| cardiac muscle cell | 4 studies | 23% ± 2% | |
| lymphocyte | 4 studies | 33% ± 14% | |
| amacrine cell | 4 studies | 23% ± 8% | |
| retinal cone cell | 4 studies | 35% ± 11% | |
| retinal rod cell | 4 studies | 30% ± 7% | |
| club cell | 4 studies | 30% ± 9% | |
| classical monocyte | 3 studies | 23% ± 3% | |
| conventional dendritic cell | 3 studies | 30% ± 12% | |
| hematopoietic precursor cell | 3 studies | 23% ± 8% | |
| non-classical monocyte | 3 studies | 21% ± 4% | |
| GABAergic interneuron | 3 studies | 29% ± 8% | |
| progenitor cell | 3 studies | 29% ± 4% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
| vein endothelial cell | 3 studies | 33% ± 20% | |
| Mueller cell | 3 studies | 35% ± 12% | |
| endothelial cell of vascular tree | 3 studies | 32% ± 19% | |
| hepatocyte | 3 studies | 40% ± 17% | |
| ependymal cell | 3 studies | 43% ± 13% | |
| alveolar macrophage | 3 studies | 37% ± 9% | |
| ciliated cell | 3 studies | 25% ± 8% | |
| respiratory goblet cell | 3 studies | 30% ± 11% | |
| basal cell | 3 studies | 44% ± 29% | |
| goblet cell | 3 studies | 38% ± 28% | |
| brush cell | 3 studies | 24% ± 3% | |
| mesothelial cell | 3 studies | 29% ± 1% | |
| mural cell | 3 studies | 32% ± 10% | |
| mucus secreting cell | 3 studies | 24% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 1439.05 | 1445 / 1445 | 100% | 9.23 | 183 / 183 |
| lung | 100% | 1593.38 | 577 / 578 | 100% | 6.96 | 1153 / 1155 |
| breast | 100% | 1561.57 | 459 / 459 | 100% | 8.31 | 1114 / 1118 |
| bladder | 100% | 1343.00 | 21 / 21 | 99% | 6.01 | 500 / 504 |
| prostate | 100% | 1481.26 | 245 / 245 | 99% | 5.06 | 498 / 502 |
| thymus | 100% | 1833.15 | 653 / 653 | 99% | 5.37 | 600 / 605 |
| pancreas | 100% | 779.75 | 328 / 328 | 99% | 5.12 | 176 / 178 |
| uterus | 100% | 1856.39 | 170 / 170 | 98% | 6.84 | 452 / 459 |
| stomach | 100% | 977.24 | 359 / 359 | 98% | 5.55 | 281 / 286 |
| intestine | 100% | 1398.33 | 966 / 966 | 98% | 4.92 | 515 / 527 |
| ovary | 100% | 1716.21 | 180 / 180 | 96% | 2.97 | 412 / 430 |
| brain | 96% | 667.00 | 2541 / 2642 | 99% | 5.02 | 701 / 705 |
| kidney | 100% | 892.64 | 89 / 89 | 94% | 3.74 | 849 / 901 |
| adrenal gland | 100% | 976.74 | 258 / 258 | 94% | 2.55 | 216 / 230 |
| skin | 100% | 2054.54 | 1809 / 1809 | 93% | 4.11 | 438 / 472 |
| liver | 100% | 680.60 | 226 / 226 | 91% | 2.72 | 370 / 406 |
| adipose | 100% | 1521.92 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1303.03 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 6.65 | 29 / 29 |
| spleen | 100% | 1469.50 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 6.65 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.80 | 1 / 1 |
| muscle | 100% | 874.88 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 741.11 | 838 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 87% | 1114.61 | 808 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 65% | 1.80 | 52 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006337 | Biological process | nucleosome disassembly |
| GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
| GO_0006334 | Biological process | nucleosome assembly |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0070577 | Molecular function | lysine-acetylated histone binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0042393 | Molecular function | histone binding |
| GO_0016887 | Molecular function | ATP hydrolysis activity |
| GO_0003682 | Molecular function | chromatin binding |
| Gene name | ATAD2B |
| Protein name | ATPase family AAA domain containing 2B ATPase family AAA domain-containing protein 2B ATAD2B protein |
| Synonyms | KIAA1240 |
| Description | |
| Accessions | ENST00000458510.1 C9JG15 ENST00000238789.10 [Q9ULI0-1] Q9ULI0 ENST00000439915.1 ENST00000381024.4 H7BYF1 Q8IWJ3 C9J1G9 |